Perspectives on Cost and Value in Cancer Care

JAMA Oncol. 2016 Jan;2(1):19-21. doi: 10.1001/jamaoncol.2015.4191.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Drug Costs*
  • Health Services Accessibility / economics*
  • Healthcare Disparities / economics*
  • Humans
  • Medical Oncology / economics*
  • Neoplasms / drug therapy*
  • Neoplasms / economics*
  • Practice Patterns, Physicians' / economics
  • Quality-Adjusted Life Years
  • Time Factors
  • Treatment Outcome
  • Value of Life

Substances

  • Antineoplastic Agents